Document Detail
Research Title: VIM - Visudyne in Minimally Classic Choroidal Neovascularization from Age-Related Macular Degeneration
Sponsor: Novartis Ophthalmics
Investigators: David H. Orth, M.D., Principal Investigator
Description: Study treating patients with Visudyne vs. placebo for the treatment of minimally classic Choroidal Neovascularization from Age-Related Macular Degeneration
Start Date: 01/01/01
Recruitment: Closed
Project Personnel: Tammy R.
Location(s): Illinois Retina Associates, S.C., 71 West 156th Street #400, Harvey, IL 60426
|